over-enrollment of patients to offset expected retention loss. The Sciformix Accelerator Methodology can be used to implement a validated, compliant, secure and hassle-fee Oracle Argus Cloud safety solution in record time. Download Schulman IRB White Paper Speeding Study Start-Up in Multicenter Clinical Trials Managing an efficient, well-organized start-up phase is critical to overall study success. Download, sciformix White Paper, real World Evidence (RWE) from Clinical Development to Patient Access. Download Clinical Ink White Paper eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials Life science companies are under increasing pressure to execute clinical trials faster with higher quality. This focus on end-benefits, however, fails to consider the deep challenges of the launch process, and companies who are not yet globally-proficient are likely to underestimate the critical role that translation plays in that effort.
Apr 15, 2018, sponsored Content, by, actiGraph. Since increasing sample size is typically associated with an increase in the statistical power of the study, the loss of subjects over the course of a trial can result in missed endpoints and negatively impact the outcome of the study. The amount of data that is generated in life sciences and health care industries is almost incomprehensible. Download, sciformix White Paper Podcast, quality Adjusted Life Year (qaly health economics plays a crucial role in informing healthcare resource allocation decisions for the reimbursed markets, explains Madhur Garg, Director, Real World Evidence and Market Access, Sciformix Corporation. Compliance, quality, and efficiency of safety processes being outsourced is a basic expectation now for more tactical areas of pharmacovigilance (PV) such as call center and case processing due to the maturity of the outsourcing and offshoring environment and processes. For pharmaceutical companies, goals may include improving a drugs position on the preferred drug list of a health plan, accelerating the availability of new treatments on a formulary, reaching an agreement on a reimbursement framework when some longer-term benefits are still unproven, and getting drugs. Electronic clinical outcome assessments, or eCOAs, employs technology such as smartphones, tablets, and personal computers to allow patients, clinicians, and their caregivers to directly report outcomes. When I read the EMA reflection paper on risk-based quality management in clinical trials, I had a déjà vu moment, or as the late baseball legend Yogi Berra would have said, "It's like déjà vu all. Qaly is often employed in the HTA process to quantify and compare health benefits of various treatment options. Increased outsourcing and globalization continue to expand the number of specialty outsourcing specialists participating in a single clinical trial.